Biotron : 5 Dec 2019Appendix 3Y – Change of Director’s Interest Notice

Level 2, 66 Hunter Street

Sydney NSW 2000

Tel: [phone]

Fax: [phone]

E-mail: [e-mail]

Website: www.biotron.com.au

5 December 2019
The Manager Companies
ASX Limited
20 Bridge Street
SYDNEY NSW 2000	(3 pages by email)
Dear Madam,

DIRECTORS' INTERESTS

In accordance with Listing Rule 3.19A, I attach an Appendix 3Y, Change of Director's Interest Notice, for Michelle Miller.

Yours sincerely

Peter J. Nightingale

Company Secretary

pjn10196

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	BIOTRON LIMITED
ABN	60 086 399 144

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Michelle MILLER
Date of last notice	2 November 2018.

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct and Indirect.
Nature of indirect interest	Michelle Miller + Peter Clarke
(including registered holder)	Super Fund A/C> in which Michelle Miller has
Note: Provide details of the circumstances giving rise to the	an interest.
relevant interest.
Date of change	5 December 2019.
No. of securities held prior to change	1,465,625 fully paid ordinary shares and 190,625
	12 December 2019, 5 cent Options held by
	Michelle Miller;1,500,000 fully paid ordinary
	shares held by Michelle Miller + Peter Clarke
	.
Class	Fully paid ordinary shares.
	12 December 2019, 5 cent listed options.

Number acquired

190,625 fully paid ordinary shares acquired on 5 December 2019 by the exercise of 12 December 2019 options.

Number disposed	190,625 12 December 2019 options exercised.
Value/Consideration	Options exercised at $0.05 per option.

Note: If consideration is non-cash, provide details and estimated valuation.

No. of securities held after change

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back.

1,656,250 fully paid ordinary shares held by Michelle Miller;1,500,000 fully paid ordinary shares held by Michelle Miller + Peter Clarke .

Exercise of options.

Appendix 3Y

Change of Director's Interest Notice

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

	Detail of contract	Nil.
	Nature of interest	N/A.
	Name of registered holder	N/A.
	(if issued securities)
	Date of change	N/A.
	No. and class of securities to which	N/A.
	interest related prior to change
	Note: Details are only required for a contract in relation to which
	the interest has changed.
	Interest acquired	N/A.
	Interest disposed	N/A.
	Value/Consideration	N/A.
	Note: If consideration is non-cash, provide details and an estimated
	valuation.
	Interest after change	N/A.
Part 3 - +Closed period
	Were the interests in the securities or	No.
	contracts detailed above traded during a
	+closed period where prior written
	clearance was required?
	If so, was prior written clearance	N/A.
	provided to allow the trade to proceed
	during this period?
	If prior written clearance was provided,	N/A.
	on what date was this provided?

+ See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011